Abstract:In this paper, we describe the development of a planar, pillar array device that can be used to image either side of a tunable membrane, as well as sample and detect small molecules in a cell-free region of the microchip. The pores are created by sealing two parallel PDMS microchannels (a cell channel and a collector channel) over a gold pillar array (5 or 10 µm in height), with the device being characterized and optimized for small molecule cross-over while excluding a flowing cell line (here, red blood cells… Show more
“…In this work, a 4 × 4 array of intersecting microchannels forming 16 independent testing areas between the electrodes of two MEAs is used to measure TEER. Leveraging this increased capacity, this platform was used to evaluate a broad experimental range of the extracellular matrix compositions and flow rates or shear stress.…”
Section: Vascular-on-chipmentioning
confidence: 99%
“…Reprinted and adapted with permission from: A (Douville et al., 2010); B (Booth and Kim, 2012); C (Walter et al., 2016); D (Brown et al., 2015); E (Deosarkar et al., 2015); F (Xu et al., 2016); and G (Selimovic et al., 2014). TEER, transepithelial electrical resistance; BBB, blood brain barrier; IDEs, interdigitated electrodes.…”
Recent advancements in electronic materials and subsequent surface modifications have facilitated real-time measurements of cellular processes far beyond traditional passive recordings of neurons and muscle cells. Specifically, the functionalization of conductive materials with ligand-binding aptamers has permitted the utilization of traditional electronic materials for bioelectronic sensing. Further, microfabrication techniques have better allowed microfluidic devices to recapitulate the physiological and pathological conditions of complex tissues and organs in vitro or microphysiological systems (MPS). The convergence of these models with advances in biological/biomedical microelectromechanical systems (BioMEMS) instrumentation has rapidly bolstered a wide array of bioelectronic platforms for real-time cellular analytics. In this review, we provide an overview of the sensing techniques that are relevant to MPS development and highlight the different organ systems to integrate instrumentation for measurement and manipulation of cellular function. Special attention is given to how instrumented MPS can disrupt the drug development and fundamental mechanistic discovery processes.
“…In this work, a 4 × 4 array of intersecting microchannels forming 16 independent testing areas between the electrodes of two MEAs is used to measure TEER. Leveraging this increased capacity, this platform was used to evaluate a broad experimental range of the extracellular matrix compositions and flow rates or shear stress.…”
Section: Vascular-on-chipmentioning
confidence: 99%
“…Reprinted and adapted with permission from: A (Douville et al., 2010); B (Booth and Kim, 2012); C (Walter et al., 2016); D (Brown et al., 2015); E (Deosarkar et al., 2015); F (Xu et al., 2016); and G (Selimovic et al., 2014). TEER, transepithelial electrical resistance; BBB, blood brain barrier; IDEs, interdigitated electrodes.…”
Recent advancements in electronic materials and subsequent surface modifications have facilitated real-time measurements of cellular processes far beyond traditional passive recordings of neurons and muscle cells. Specifically, the functionalization of conductive materials with ligand-binding aptamers has permitted the utilization of traditional electronic materials for bioelectronic sensing. Further, microfabrication techniques have better allowed microfluidic devices to recapitulate the physiological and pathological conditions of complex tissues and organs in vitro or microphysiological systems (MPS). The convergence of these models with advances in biological/biomedical microelectromechanical systems (BioMEMS) instrumentation has rapidly bolstered a wide array of bioelectronic platforms for real-time cellular analytics. In this review, we provide an overview of the sensing techniques that are relevant to MPS development and highlight the different organ systems to integrate instrumentation for measurement and manipulation of cellular function. Special attention is given to how instrumented MPS can disrupt the drug development and fundamental mechanistic discovery processes.
“…Pores between two parallel flow channels were created using a 3‐dimensional gold pillar array embedded within the polystyrene base. The pillars gated RBCs in one channel and allowed NO (produced by making the cells hypoxic) to pass through the pores into the adjacent flow channel for subsequent electrochemical detection at the cell‐free electrode . However, this initial design only explored the use of non‐adherent cells (RBCs) and did not involve any cell‐to‐cell communication work.…”
Section: Figurementioning
confidence: 99%
“…The detection electrode was also modified with Nafion, a cation exchange polymer that repels negatively charged interferents such as nitrite, which is oxidized at potentials similar to NO . The use of Nafion to diminish nitrite signals has been previously published . Using the glassy carbon detection electrode modified with platinum‐black and 0.05 % Nafion, a limit of detection of 475 nM NO was observed.…”
We describe a microfluidic device that can be used to detect interactions between red blood cells (RBCs) and endothelial cells using a gold pillar array (created by electrodeposition) and an integrated detection electrode. Endothelial cells can release nitric oxide (NO) via stimulation by RBC‐derived ATP. These studies incorporate on‐chip endothelial cell immobilization, direct RBC contact, and detection of NO in a single microfluidic device. In order to study the RBC‐EC interactions, this work used a microfluidic device made of a PDMS chip with two adjacent channels and a polystyrene base with embedded electrodes for creating a membrane (via gold pillars) and detecting NO (at a glassy carbon electrode coated with platinum‐black and Nafion). RBCs were pharmacologically treated with treprostinil in the absence and presence of glybenclamide, and ATP release was determined as was the resultant NO release from endothelial cells. Treprostinil treatment of RBCs resulted in ATP release that stimulated endothelial cells to release on average 1.8±0.2 nM NO per endothelial cell (average±SEM, n=8). Pretreatment of RBCs with glybenclamide inhibited treprostinil‐induced ATP release and, therefore, less NO was produced by the endothelial cells (0.92±0.1 nM NO per endothelial cell, n=7). In the future, this device can be used to study interactions between many other cell types (both adherent and non‐adherent cell lines) and incorporate other detection schemes.
“…Although being still in their very early developmental stage, some microfluidic platforms appear as innovative systems for significant endocrine studies. Concerning the adrenal glands, microfluidics is being applied to detect and study corticosteroids [ 167 , 168 , 170 ] and catecholamines [ 165 , 166 , 171 ]. In the fertility context, Huang and collaborators used microfluidics to isolate, analyze and quantify spermatozoids [ 163 ].…”
Section: Convergence Between Microfluidics and Tissue Engineering:mentioning
Recent advances in biomedical technologies are mostly related to the convergence of biology with microengineering. For instance, microfluidic devices are now commonly found in most research centers, clinics and hospitals, contributing to more accurate studies and therapies as powerful tools for drug delivery, monitoring of specific analytes, and medical diagnostics. Most remarkably, integration of cellularized constructs within microengineered platforms has enabled the recapitulation of the physiological and pathological conditions of complex tissues and organs. The so-called “organ-on-a-chip” technology, which represents a new avenue in the field of advanced in vitro models, with the potential to revolutionize current approaches to drug screening and toxicology studies. This review aims to highlight recent advances of microfluidic-based devices towards a body-on-a-chip concept, exploring their technology and broad applications in the biomedical field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.